logo Hematology/Oncology Research Studies: Open for Enrollment Date: 05/27/20


Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine

NCT#/Phase: NCT02679144
Phase 2
IRB#: 2016-100
Description: This multicenter study will evaluate the efficacy of difluoromethylornithine (DFMO) as a single agent in preventing relapse in patients with high-risk neuroblastoma who are in remission.
Inclusion: Individuals who are < 31 years of age who have a pathologically confirmed diagnosis of neuroblastoma and are classified as high risk by the criteria used by COG or SIOPEN at the time of diagnosis. All Individuals must be in complete remission (CR).
Enrollment Status: Open for enrollment
Sponsor: Beat Childhood Cancer (BCC)
Principal Investigator(s): Anu Agrawal, MD
Contact(s): Anu Agrawal, MD (510-428-3885 x3539)
Jennifer Michlitsch, MD
Study Link: https://clinicaltrials.gov/ct2/show/NCT02679144

UCSF Benioff Children's Hospital Oakland • 747 52nd Street, Oakland, California 94609 &bull Phone: (510) 428-3000